»ó´Ü¿©¹é
±â»ç (Àüü 443°Ç)
[Deep in Guideline] ³úÁ¹ÁßÀӻ󿬱¸¼¾ÅÍ ³úÁ¹Áß Áø·áÁöħ Review ÀÓ¼¼Çü ±âÀÚ 2014-03-14 18:00
[Deep in Guideline] ³úÁ¹ÁßÀ¸·Î °¡´Â °¡Àå Å« ±æ¸ñÀ» ÁöÄѶó ÀÌ»óµ· ±âÀÚ 2014-03-14 17:52
[Interview] Çѱ¹ÀÎ ´ë»çÁõÈıº ½ÇÅÂ¿Í À¯º´ Ư¼º ÀÓ¼¼Çü ±âÀÚ 2014-02-10 15:37
[Sub Story] ´ë»çÁõÈıº ÀÎÀÚ °ü¸® Àü·« : ÀÌ»óÁöÁúÇ÷Áõ ÀÌ»óµ· ±âÀÚ 2014-02-10 15:15
[¹ÌºÐ·ù] ´ë»çÁõÈıº ÀÎÀÚ °ü¸® Àü·« : °íÇ÷´ç ÀÓ¼¼Çü ±âÀÚ 2014-02-10 15:05
¶óÀÎ
[Sub Story] ´ë»çÁõÈıº ÀÎÀÚ °ü¸® Àü·« : °íÇ÷´ç ÀÓ¼¼Çü ±âÀÚ 2014-02-10 14:17
[Drug Review] ·Î¹ÙƼź, ·Î¼ö¹Ù½ºÅ¸Æ¾ + ¹ß»ç¸£Åº º¹ÇÕÁ¦ ¹Ú»óÁØ ±âÀÚ 2014-02-10 13:42
[Drug Review] º§ºò, ȯÀÚ±º 48% 1³â ÈÄ 5% ÀÌ»ó °¨·® ¹Ú»óÁØ ±âÀÚ 2014-02-10 12:05
[Hot Discussion] Æú¸®ÇÊ, ½ÉÇ÷°üÁúȯ ±Øº¹ ¿©Á¤ÀÇ ¿À¾Æ½Ã½ºÀΰ¡, ½Å±â·çÀΰ¡ ÀÌ»óµ· ±âÀÚ 2014-02-10 11:27
[Late Breaking Studies] Ç÷´ç°­ÇÏ ¿ä¹ý ½ÃÀÛ ÈÄ Ã¼ÁßÀÇ º¯È­ ÀÌ»óµ· ±âÀÚ 2014-02-10 11:14
¶óÀÎ
[Hot Discussion] ´ë»çÁõÈıº ½Çü¿¡ ´ëÇÑ Á¢±Ù°ú ÀÓ»óÇöÀåÀÇ °ü¸® ÀÌ»óµ· ±âÀÚ 2014-02-10 10:53
[Deep in Guideline] AHA¡¤NHLBI ´ë»çÁõÈıºÀÇ Áø´Ü¡¤Ä¡·á °¡À̵å¶óÀÎ ÀÌ»óµ· ±âÀÚ 2014-02-10 10:43
[Deep in Guideline] AHA¡¤ACC¡¤TOS °úüÁß ¹× ºñ¸¸ ¼ºÀÎ °ü¸® °¡À̵å¶óÀÎ ÀÓ¼¼Çü ±âÀÚ 2014-02-10 10:34
[Conference Report] ¹Ì±¹½ÉÀåÇùȸ 2013³â ¿¬·ÊÇмú´ëȸ ´ë»çÁõÈıº °ü·Ã ¿¬±¸ ÀÓ¼¼Çü ±âÀÚ 2014-02-10 10:17
[Sub Story] SGLT-2 ¾ïÁ¦Á¦ - Ä«³ª±Û¸®Ç÷ÎÁø¡¤¿¥Æı۸®Ç÷ÎÁø ÀÓ¼¼Çü ±âÀÚ 2014-01-16 14:55
¶óÀÎ
[Sub Story] ´ëÇÑ´ç´¢º´ÇÐȸ ¹× ¹Ì±¹´ç´¢º´ÇÐȸ - ½ÉÇ÷°üÁúȯ ¿¹¹æÀü·« ÀÓ¼¼Çü ±âÀÚ 2014-01-16 14:50
[Drug Review] PPAR-¥ã°è¿­ÀÇ ÅäÁ¾ ´ç´¢º´ Ä¡·áÁ¦ - µàºñ¿¡ ¹Ú»óÁØ ±âÀÚ 2014-01-16 14:16
[Sub Story] ¡°SGLT-2 ¾ïÁ¦Á¦ üÁß°¨¼Ò È¿°ú ¸Å·ÂÀû¡¦¾ÈÀü¼ºÀº Á» ´õ ºÁ¾ß¡± ¹Ú»óÁØ ±âÀÚ 2014-01-16 13:57
[Deep in Guideline] 2013 ESC_EASD ´ç´¢º´¡¤´ç´¢º´Àü´Ü°è¡¤½ÉÇ÷°üÁúȯ °¡À̵å¶óÀÎ 2 ÀÌ»óµ· ±âÀÚ 2014-01-16 11:02
[Conference Report] 2013 ¹Ì±¹½ÉÀåÇùȸ ¿¬·ÊÇмú´ëȸ ÇÏÀ̶óÀÌÆ® ÀÓ¼¼Çü ±âÀÚ 2013-12-16 09:09
Back to Top